In Vitro Activity of Ceftolozane/Tazobactam and Imipenem/Relebactam in Clinical Isolates of Pseudomonas Aeruginosa and Enterobacterales Collected From Hematology and Oncology Patients
Clinical trial NCT04196608 · UNKNOWN
Trial details
- NCT number
- NCT04196608
- Sponsor
- Emilio Bouza
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-01
- Primary completion
- 2020-05-31
- Enrollment
- 1005
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.